Cargando…
Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
Since the start of the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) pandemic, several treatments have been proposed to cure coronavirus disease 2019 (COVID‐19) and prevent it. Molnupiravir is a ribonucleoside prodrug of N‐hydroxycytidine with an in vitro and in vivo activity against...
Autores principales: | De Vito, Andrea, Colpani, Agnese, Bitti, Alessandra, Zauli, Beatrice, Meloni, Maria Chiara, Fois, Marco, Denti, Lucia, Bacciu, Sara, Marcia, Claudia, Maida, Ivana, Babudieri, Sergio, Madeddu, Giordano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349683/ https://www.ncbi.nlm.nih.gov/pubmed/35855627 http://dx.doi.org/10.1002/jmv.28011 |
Ejemplares similares
-
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression
por: De Vito, Andrea, et al.
Publicado: (2022) -
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?
por: De Vito, Andrea, et al.
Publicado: (2023) -
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population
por: De Vito, Andrea, et al.
Publicado: (2022) -
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience
por: Donisi, Alessandra, et al.
Publicado: (2023) -
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free
por: Fiore, Vito, et al.
Publicado: (2022)